Gain of function, loss of control - a molecular basis for chronic myeloproliferative disorders
- PMID: 15996923
Gain of function, loss of control - a molecular basis for chronic myeloproliferative disorders
Comment on
-
Targeting mutated protein tyrosine kinases and their signaling pathways in hematologic malignancies.Haematologica. 2005 Jul;90(7):949-68. Haematologica. 2005. PMID: 15996933 Review.
Similar articles
-
A unifying mutation in chronic myeloproliferative disorders.N Engl J Med. 2005 Apr 28;352(17):1744-6. doi: 10.1056/NEJMp058083. N Engl J Med. 2005. PMID: 15858182 No abstract available.
-
Diagnostic assays for the JAK2 V617F mutation in chronic myeloproliferative disorders.Am J Clin Pathol. 2006 May;125(5):651-3. doi: 10.1309/NXXT-GRCX-D0TM-A3C2. Am J Clin Pathol. 2006. PMID: 16707363 No abstract available.
-
[New molecular markers within the chronic myeloproliferative disorders. II: the JAK2 mutation].Ugeskr Laeger. 2006 Sep 25;168(39):3299-303. Ugeskr Laeger. 2006. PMID: 17032592 Review. Danish.
-
[A recurrent mutation of the JAK2 gene in chronic myeloproliferative disorders].Pathol Biol (Paris). 2006 May;54(4):182-4. doi: 10.1016/j.patbio.2005.07.002. Epub 2005 Aug 3. Pathol Biol (Paris). 2006. PMID: 16084028 Review. French. No abstract available.
-
A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospects.Trends Mol Med. 2005 Dec;11(12):546-54. doi: 10.1016/j.molmed.2005.10.003. Epub 2005 Nov 3. Trends Mol Med. 2005. PMID: 16271512 Review.
Cited by
-
Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms.Blood. 2013 May 23;121(21):4388-95. doi: 10.1182/blood-2013-02-486050. Epub 2013 Apr 10. Blood. 2013. PMID: 23575445 Free PMC article.
-
The Role of MicroRNAs in Myeloproliferative Neoplasia.Int J Hematol Oncol Stem Cell Res. 2016 Jul 1;10(3):172-85. Int J Hematol Oncol Stem Cell Res. 2016. PMID: 27489593 Free PMC article. Review.
-
Clinical relevance of JAK2 (V617F) mutant allele burden.Haematologica. 2009 Jan;94(1):7-10. doi: 10.3324/haematol.2008.001271. Haematologica. 2009. PMID: 19118374 Free PMC article.
-
Polycythaemia vera and essential thrombocythaemia: current treatment strategies.Drugs. 2006;66(17):2173-87. doi: 10.2165/00003495-200666170-00003. Drugs. 2006. PMID: 17137402 Review.
-
Development of a high resolution melting analysis assay for rapid identification of JAK2 V617F missense mutation and its validation.Exp Hematol Oncol. 2019 Apr 30;8:10. doi: 10.1186/s40164-019-0134-0. eCollection 2019. Exp Hematol Oncol. 2019. PMID: 31165012 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous